Pfizer ¶¶Òõ¶ÌÊÓƵ, a subsidiary of the global American company Pfizer, announced the appointment of Dr. Hani Al-Hashmi as the company’s senior medical director and official spokesperson.
This appointment is the latest addition to the company’s medical leadership team in the region.Â
Al-Hashmi has a wealth of experience and has held a number of important positions, the last of which was director of the Oncology Center at King Fahad Specialist Hospital in Dammam.Â
He completed his university studies in medical technology at King Abdul Aziz University in 1999.
He then went to McMaster University, Canada, where he obtained his doctorate in medicine in 2003.
Al-Hashmi received his postgraduate training in internal medicine at the University of Western Ontario.
He obtained a hematology fellowship from McMaster University, and a fellowship in oncology and hematopoietic stem cell transplantation from the University of Calgary.Â
He spent the last part of his training at the Fred Hutchinson Cancer Research Center in Seattle, and completed an executive master’s degree in health administration from the University of Alabama.
He has presented several scientific papers on topics including lymphoma, service development and health economics.
Al-Hashmi has extensive experience in developing medical services and formulating related policies and strategies.
He previously led the National Strategy for Cancer Care and Specialized Oncology Services at the Ministry of Health.
Over the past 10 years, he helped establish five stem cell transplantation programs and more than 10 oncology departments throughout the Kingdom.
He also participated in developing future strategies, clinical services, and education and research in hematology, oncology and cellular therapy nationally and regionally.Â
He also worked on several national committees at the Ministry of Health, the Saudi Health Council and the Saudi Commission for Health Specialties.
Al-Hashmi expressed his pleasure at his appointment, saying Pfizer aspires to provide the best health care for patients worldwide.
He stressed his commitment to harnessing all his expertise in his new role.
